HIV news from aidsmap.com

The war on science: resisting and rebuilding at a crucial juncture
Peter Staley’s talk at the opening session of the Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver was a grim post-mortem of one of the most challenging years in recent HIV history – an ‘annus horribilis’ – a phrase Queen Elizabeth II used to describe 1992 and The Lancet applied to 2025.
>> Read more

CD8 cell fitness predicts who benefits most from antibody-based cure strategies
Over the last few years a number of studies aiming to cure HIV or at least achieve long-term viral suppression off antiretroviral therapy (ART) have produced tantalising results. These studies have given participants one or both of the long-acting versions of two broadly neutralising antibodies (bnAbs), 3BNC117 (teropavimab) and 10-1074 (zinlirvimab), sometimes in conjunction with immune boosting oral drugs.
>> Read more

News from CROI 2026 coming soon
The 33rd Conference on Retroviruses and Opportunistic Infections (CROI 2026) is taking place in Denver, US, from 22 to 25 February. CROI is an annual scientific conference and was established to “provide a forum for basic scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases”. CROI 2026 will feature research and discussions on:
>> Read more